WO2009106824A3 - Pharmaceutical formulations with a taste masking coating - Google Patents

Pharmaceutical formulations with a taste masking coating Download PDF

Info

Publication number
WO2009106824A3
WO2009106824A3 PCT/GB2009/000529 GB2009000529W WO2009106824A3 WO 2009106824 A3 WO2009106824 A3 WO 2009106824A3 GB 2009000529 W GB2009000529 W GB 2009000529W WO 2009106824 A3 WO2009106824 A3 WO 2009106824A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical formulations
taste masking
masking coating
combination
active ingredient
Prior art date
Application number
PCT/GB2009/000529
Other languages
French (fr)
Other versions
WO2009106824A2 (en
Inventor
Amar Lulla
Geena Malhotra
Philip Anthony Curtis
Original Assignee
Cipla Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Limited filed Critical Cipla Limited
Publication of WO2009106824A2 publication Critical patent/WO2009106824A2/en
Publication of WO2009106824A3 publication Critical patent/WO2009106824A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An oral pharmaceutical formulation comprising an active ingredient in combination with one or more pharmaceutical adjuvants, wherein the active ingredient, or combination of the active ingredient and the or each adjuvant, is coated with water soluble polymer or combination of a water soluble and a water insoluble polymer.
PCT/GB2009/000529 2008-02-25 2009-02-25 Pharmaceutical formulations WO2009106824A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN388MU2008 2008-02-25
IN388/MUM/2008 2008-02-25

Publications (2)

Publication Number Publication Date
WO2009106824A2 WO2009106824A2 (en) 2009-09-03
WO2009106824A3 true WO2009106824A3 (en) 2010-05-14

Family

ID=40635450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/000529 WO2009106824A2 (en) 2008-02-25 2009-02-25 Pharmaceutical formulations

Country Status (1)

Country Link
WO (1) WO2009106824A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010024866A1 (en) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulation for taste masking
CA2805568A1 (en) 2010-07-08 2012-01-12 Ratiopharm Gmbh Oral dosage form of deferasirox
DK3124018T3 (en) 2013-03-08 2018-03-26 Novartis Ag Oral formulations of deferasirox
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
MX365914B (en) 2013-03-15 2019-06-20 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate.
CN103735519A (en) * 2014-01-10 2014-04-23 无锡万全医药技术有限公司 Deferasirox granules and preparation method thereof
EP2987482A1 (en) * 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
WO2016167729A1 (en) * 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3675832A1 (en) * 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
GR1009592B (en) 2018-07-03 2019-09-11 Φαρματεν Α.Β.Ε.Ε. Pharmaceutical composition comprising an iron chelating agent and method for the preparation thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317274A1 (en) * 1987-11-16 1989-05-24 McNEIL-PPC, INC. Chewable medicament tablet containing means for taste masking
GB2217598A (en) * 1988-03-25 1989-11-01 Ciba Geigy Effervescent tablet containing diclofenac
WO2002092106A1 (en) * 2001-05-11 2002-11-21 Pacific Pharmaceuticals Limited Taste masking pharmaceutical composition
US20030203954A1 (en) * 1996-06-25 2003-10-30 Rene Lattmann Substituted 3, 5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
WO2004035026A1 (en) * 2002-10-15 2004-04-29 Novartis Ag Deferacirox dispersible tablets
WO2009016359A1 (en) * 2007-07-27 2009-02-05 Pliva Hrvatska D.O.O. New forms of deferasirox
EP2062572A1 (en) * 2007-11-19 2009-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317274A1 (en) * 1987-11-16 1989-05-24 McNEIL-PPC, INC. Chewable medicament tablet containing means for taste masking
GB2217598A (en) * 1988-03-25 1989-11-01 Ciba Geigy Effervescent tablet containing diclofenac
US20030203954A1 (en) * 1996-06-25 2003-10-30 Rene Lattmann Substituted 3, 5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
WO2002092106A1 (en) * 2001-05-11 2002-11-21 Pacific Pharmaceuticals Limited Taste masking pharmaceutical composition
WO2004035026A1 (en) * 2002-10-15 2004-04-29 Novartis Ag Deferacirox dispersible tablets
WO2009016359A1 (en) * 2007-07-27 2009-02-05 Pliva Hrvatska D.O.O. New forms of deferasirox
EP2062572A1 (en) * 2007-11-19 2009-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions

Also Published As

Publication number Publication date
WO2009106824A2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
WO2009106824A3 (en) Pharmaceutical formulations with a taste masking coating
WO2008149440A1 (en) Medicinal film preparation with rapidly dissolving property and flexibility
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2010027735A3 (en) Coating on a balloon comprising a polymer and a drug
EP1889609A3 (en) Immune response modifier foam formulations
WO2012022919A3 (en) Nalbuphine-based formulations and uses thereof
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2002030398A3 (en) Delayed release pharmaceutical formulations
WO2012009684A3 (en) Drug delivery medical device
WO2007109057A3 (en) Solid dosage form containing a taste masked active agent
WO2009048148A1 (en) Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
WO2010009140A3 (en) Methods, systems and devices for administration of chlorine dioxide
WO2010021607A3 (en) Pharmaceutical formulation
WO2006008173A3 (en) Pharmaceutical formulations for inhalation
WO2009061431A3 (en) Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2005027843A3 (en) Chronotherapeutic dosage forms
WO2009072334A1 (en) Core particle for pharmaceutical preparation
WO2010084088A3 (en) Starch nanoparticles for drug delivery systems
WO2009068708A3 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
MX2009008197A (en) Extended-release dosage form.
WO2012092486A3 (en) Modified release benzimidazole formulations
WO2009013356A3 (en) Anti-hiv tablet formulations comprising darunavir
WO2009139504A3 (en) A solid pharmaceutical formulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09715119

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 1782/MUMNP/2010

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09715119

Country of ref document: EP

Kind code of ref document: A2